Group 1 - The core viewpoint of the news is the significant growth in the general aviation sector, highlighted by the rise of the Zhongzheng General Aviation Theme Index and the successful launch of the "Chuan Yue Zhe No. 1" commercial manned spacecraft [1] - As of January 23, 2026, the Zhongzheng General Aviation Theme Index (931855) increased by 2.02%, with notable stock performances from Tianyin Electromechanical (+8.41%), Plater (+7.04%), and Huali Chuangtong (+4.90%) [1] - The general aviation ETF fund (561660) rose by 1.85%, with the latest price reported at 1.43 yuan [1] Group 2 - The "Chuan Yue Zhe No. 1" spacecraft has already secured over three spacecraft seats for more than 20 space tourists, with the first manned flight expected in 2028 [1] - Huachuang Securities reports that the commercial aviation engine market in China has immense potential, estimating a total market size exceeding 2.6 trillion yuan over the next 20 years, with an annualized scale of over 130 billion yuan [1] - The aftermarket for commercial aviation engines is projected to reach approximately 100 billion yuan annually, with a combined market potential of 240 billion yuan per year [1] - Recommendations include focusing on three key areas within the domestic aviation engine supply chain: core component suppliers, high-temperature alloy suppliers, and raw material suppliers [1] Group 3 - The Zhongzheng General Aviation Theme Index closely tracks 50 listed companies involved in aviation materials, components, aircraft manufacturing, infrastructure, operations, and applications [2] - As of December 31, 2025, the top ten weighted stocks in the Zhongzheng General Aviation Theme Index include Aerospace Electronics, Haige Communication, China Satellite Communications, and others, collectively accounting for 43.4% of the index [2]

Monetary Policy and Economic Measures - The central bank governor Pan Gongsheng stated that a moderately loose monetary policy will continue in 2026, with room for further cuts in reserve requirement ratios and interest rates to maintain ample liquidity [3] - The first batch of 936 billion yuan of ultra-long special government bonds has been allocated to support approximately 4,500 projects in various sectors, expected to drive total investment exceeding 460 billion yuan [4] - The People's Bank of China will conduct a 900 billion yuan MLF operation on January 23, net injecting 700 billion yuan into the market, marking the 11th consecutive month of increased operations [4] Consumer and Investment Trends - State-owned banks collectively announced the implementation of personal consumption loan interest subsidy policies, allowing some high-quality clients to enjoy effective interest rates in the "2%" range, lower than current housing loan rates [3] - Public funds have focused their fourth-quarter 2025 positions on core sectors such as electronics and power equipment, with Zhongji Xuchuang becoming the largest holding stock [3] Market Performance - The A-share market saw a slight increase, with the Shanghai Composite Index rising 0.14% to 4122.58 points, and the Shenzhen Component Index increasing by 0.5% [6] - The Hong Kong stock market also experienced minor fluctuations, with the Hang Seng Index rising 0.17% to 26629.96 points, and net inflows from southbound funds amounting to 5.166 billion HKD [6] Corporate Developments - Alibaba Group has decided to support its chip company "Pingtouge" for independent listing, with plans for restructuring to a mixed-ownership enterprise [7] - Xiaomi Group has initiated a stock repurchase plan of up to 2.5 billion HKD [9] - Nanjing Bank reported a net profit growth of 8.08% year-on-year for 2025 [9] Regulatory and Policy Updates - The State Administration for Market Regulation has issued a red card for the first time in the public utility sector, prohibiting a merger between two gas companies [10] - Nine departments jointly issued opinions to promote high-quality development in the pharmaceutical retail industry, encouraging mergers and acquisitions among retail pharmacies [10] Economic Indicators - The unemployment rate for urban labor aged 16-24 was reported at 16.5% in December 2025, while the rate for those aged 25-29 was 6.9% [5] - The National Bureau of Statistics reported a 28.1% year-on-year increase in sales revenue for the smart device manufacturing industry in 2025 [10]

Core Viewpoint - The company anticipates a negative net profit for the fiscal year 2025, focusing on strategic adjustments and market opportunities to mitigate losses [2][3]. Group 1: Performance Forecast - The performance forecast period is set from January 1, 2025, to December 31, 2025, with an expected net profit in negative territory [1]. - The company has communicated its performance forecast with its auditing firm, and there are no discrepancies reported [2]. Group 2: Reasons for Performance Changes - The company is concentrating on its core businesses, including smart positioning digital bases and ceramic components, which has led to a reduction in losses for the parent net profit [3]. - Rapid expansion in demand for emerging sectors such as lawn mowers, smart driving, and consumer electronics has significantly increased revenue from core product lines, contributing to profit growth [3]. - A strategic acquisition of Shenzhen Tianli has enabled the company to enhance its antenna business in automotive applications, further increasing revenue and profit [3]. - The company plans to recognize an impairment of goodwill amounting to approximately 150 million yuan due to current market conditions and accounting standards [4]. - The company has increased its investment in integrated cloud core technology, with total R&D expenditures reaching about 430 million yuan for the year [5]. - The company has proactively reduced its special equipment business, resulting in a significant decline in revenue and substantial losses in parent net profit compared to the same period last year [6].

Group 1 - The company expects a net profit in the range of negative values for the fiscal year 2025, from January 1 to December 31 [2][3] - The company has communicated with its auditing firm regarding the performance forecast, and there are no disagreements between the company and the auditors [3] - The company aims to reduce losses in net profit by focusing on its core businesses, including smart positioning digital base and ceramic components, and has seen significant revenue growth in core product lines due to demand in emerging fields [4][5] Group 2 - The company plans to recognize an impairment of goodwill amounting to approximately 150 million yuan due to changes in the market environment and accounting standards [5] - The company has increased its investment in integrated cloud core technology, with total R&D expenditures expected to be around 430 million yuan for the year [6] - The company has actively reduced its special equipment business, resulting in a significant decline in revenue and substantial losses in net profit compared to the same period last year [7]

Major Announcements - Zhaoyi Innovation plans to use 500 million CNY of A-share fundraising to increase capital in its wholly-owned subsidiaries for the implementation of the DRAM project [1] - Haiguang Information's mid-2025 profit distribution plan includes a cash dividend of 0.09 CNY per share, totaling 209 million CNY [2] - *ST Biology has terminated the major asset restructuring plan to acquire 51% of Hunan Huize Biomedical Technology Co., Ltd. [3] - Fosun Pharma intends to spin off its subsidiary Fosun Antigen for independent listing on the Hong Kong Stock Exchange [4] - Jingchen Co. has set the inquiry transfer price at 82.85 CNY per share for the transfer of 13.1 million shares [5] Performance Forecasts - Zhaoyi Innovation expects a net profit of approximately 1.61 billion CNY for 2025, a year-on-year increase of about 46% [9] - Longying Precision anticipates a net profit decrease of 17.70% to 29.36% for 2025, estimating between 545 million CNY and 635 million CNY [9] - Ruichuang Micro-Nano forecasts a net profit of around 1.1 billion CNY for 2025, representing a 93% increase [10] - Nanjing Bank projects a net profit of 21.81 billion CNY for 2025, an 8.08% increase year-on-year [11] - Zhongyuan Co. expects a net profit increase of 80% to 105% for 2025, estimating between 139 million CNY and 158 million CNY [12] - Qiangyi Co. anticipates a net profit increase of 57.87% to 71.17% for 2025, estimating between 368 million CNY and 399 million CNY [13] - Liard expects a net profit of 300 million CNY to 380 million CNY for 2025, turning from a loss of 889 million CNY in the previous year [14] - Daheng Technology forecasts a net profit of approximately 106 million CNY for 2025, also turning from a loss [16] - Dongfeng Co. anticipates a net loss of 390 million CNY to 480 million CNY for 2025 [17] - Qing Song Co. expects a net profit increase of 137.73% to 201.74% for 2025, estimating between 130 million CNY and 165 million CNY [18] - SIRUI Co. forecasts a net profit of 165 million CNY to 184 million CNY for 2025, turning from a loss [19] - Shengmei Shanghai expects a revenue increase of 18.91% to 22.47% for 2025, estimating between 6.68 billion CNY and 6.88 billion CNY [20] - Yijun Co. anticipates a net loss of 11 million CNY to 14 million CNY for 2025 [21] - Saint Yuan Environmental Protection expects a net profit increase of 31.79% to 59.24% for 2025, estimating between 240 million CNY and 290 million CNY [22] - Lijun Co. forecasts a net profit decrease of 45.05% to 60.03% for 2025, estimating between 4.8 million CNY and 6.6 million CNY [23] - Xingqi Eye Medicine expects a net profit increase of 95.82% to 121.56% for 2025, estimating between 662 million CNY and 749 million CNY [25] - Beidou Star expects a net loss of 230 million CNY to 290 million CNY for 2025, reducing losses compared to the previous year [26] - Yiling Pharmaceutical anticipates a net profit of 1.2 billion CNY to 1.3 billion CNY for 2025, turning from a loss of 725 million CNY [27] - Zhijiang Bio forecasts a net loss of 32 million CNY to 47 million CNY for 2025, reducing losses compared to the previous year [28] - Yema Battery expects a net profit decrease of 58% to 70% for 2025, estimating between 45.83 million CNY and 64.17 million CNY [29] - Yunmei Energy anticipates a net loss of 410 million CNY to 470 million CNY for 2025 [30] - Yingfang Micro expects a net loss of 69 million CNY to 97 million CNY for 2025 [31] - Guanghua Technology forecasts a net profit of 85 million CNY to 120 million CNY for 2025, turning from a loss [33] Share Buybacks - Hengyi Petrochemical plans to repurchase shares worth 500 million CNY to 1 billion CNY [34] - Yunyi Electric plans to repurchase shares worth 100 million CNY to 150 million CNY [34] - Xidun Pharmaceutical plans to repurchase shares worth 25 million CNY to 50 million CNY [35]

北斗星通（002151）(002151.SZ)披露2025年度业绩预告，公司预计归属于上市公司股东的净亏损2.3亿 元至2.9亿元;扣除非经常性损益后的净亏损2.9亿元至3.5亿元。 ...

智通财经APP讯，北斗星通(002151.SZ)披露2025年度业绩预告，公司预计归属于上市公司股东的净亏损 2.3亿元至2.9亿元;扣除非经常性损益后的净亏损2.9亿元至3.5亿元。 ...

Investment Announcements - Chongda Technology's subsidiary, Punowei, plans to invest 1 billion yuan in a functional IC packaging substrate project to enhance competitiveness in the high-end integrated circuit substrate sector, with construction expected to start in September 2026 and completion by September 2028 [2] - Hualing Steel's subsidiary, Hunan Hualing Lianyuan Steel, intends to invest approximately 44.99 million yuan in a major overhaul of a coking plant to address aging issues and improve production capacity while complying with environmental regulations [4] - Licheng Group's subsidiary has received a project notification for aluminum alloy wheels from a well-known international automotive manufacturer, with an estimated sales amount of about 1.37 billion yuan over the project's lifecycle [23] Financial Performance - *ST Rock reported significant stock price volatility and faces financial delisting risks, with a projected revenue of 34.76 million yuan and a net loss of 112 million yuan for the first three quarters of 2025 [3] - Zhengping Co. announced a net loss of 484 million yuan for 2024, with a revenue of 1.362 billion yuan, and faces multiple risks including insufficient mining capacity [5] - Lijun Co. expects a net profit of 48 million to 66 million yuan for 2025, a decrease of 45.05% to 60.03% year-on-year due to increased competition and rising costs [7] - Fangzheng Technology anticipates a net profit of 430 million to 510 million yuan for 2025, representing a year-on-year increase of 67.06% to 98.14% driven by AI and high-value business orders [8] - Xingqi Eye Medicine expects a net profit of 662 million to 749 million yuan for 2025, reflecting a growth of 95.82% to 121.56% due to enhanced market expansion and product optimization [9] - Shennan Electric A forecasts a net profit of 150 million to 180 million yuan for 2025, a substantial increase of 584.66% to 721.59% attributed to asset disposals and improved energy services [10] - Yunmei Energy anticipates a net loss of 410 million to 470 million yuan for 2025, with a reduction in losses compared to the previous year due to market conditions [11] - Yaxin Security expects a net loss of 380 million to 500 million yuan for 2025, a shift from a profit of 9.59 million yuan in the previous year, primarily due to operational pressures [12] - Beidouxing Tong forecasts a net loss of 230 million to 290 million yuan for 2025, with a focus on core business areas despite ongoing losses [13] - Liard expects a net profit of 300 million to 380 million yuan for 2025, marking a turnaround from a loss of 889 million yuan in the previous year, driven by strategic transformation [14] - Changying Precision anticipates a net profit of 545 million to 635 million yuan for 2025, a decline of 17.70% to 29.36% year-on-year due to the absence of non-recurring gains [15][16] - Yiling Pharmaceutical expects a net profit of 1.2 billion to 1.3 billion yuan for 2025, recovering from a loss of 725 million yuan in the previous year through improved management and cost control [17] Share Buybacks and Stock Movements - Xidun Pharmaceutical plans to repurchase shares worth 25 million to 50 million yuan at a price not exceeding 42 yuan per share [19] - Zhongwei Company reported that its largest shareholder reduced its stake by 1% through block trading, completing the planned reduction [21] Major Contracts - *ST Songfa's subsidiary signed contracts for the construction of two VLCC super-large oil tankers, with a contract value of approximately 200 million to 300 million USD, expected to positively impact the company's performance [25]

Group 1 - Huakang Clean announced it is the first candidate for the bid of the Wuhan First Hospital expansion project with a bid amount of 54.88 million yuan and a construction period of 120 days [1] - Hualing Steel's subsidiary plans to invest 449.88 million yuan in a major overhaul project for its coking plant, aiming to address aging issues and restore production capacity over a 19-month construction period [2] - Yinjia Technology expects a net loss of 140 million to 110 million yuan for 2025, compared to a loss of 129 million yuan in the previous year [3] Group 2 - Guochuang High-tech forecasts a net profit of 16 million to 24 million yuan for 2025, recovering from a loss of 58.52 million yuan in the previous year [4] - Shiyi Da anticipates a net profit increase of 31 million to 46 million yuan for 2025, turning around from a loss of 23.41 million yuan last year [5] - Lijun Co. expects a net profit of 48 million to 66 million yuan for 2025, representing a decline of 45.05% to 60.03% compared to the previous year [7] Group 3 - Xindian Pharmaceutical plans to repurchase shares worth 25 million to 50 million yuan for employee stock ownership plans or equity incentives, with a maximum repurchase price of 42 yuan per share [6] - Jingchen Co. has set the initial transfer price for its shares at 82.85 yuan per share, with a total of 13.1 million shares to be transferred to 28 institutional investors [8] - Zejing Pharmaceutical received approval for clinical trials of its innovative cancer immunotherapy drug ZG005 in combination with platinum-based chemotherapy for advanced nasopharyngeal and esophageal squamous cell carcinoma [9] Group 4 - Xingqi Eye Medicine expects a net profit of 662 million to 749 million yuan for 2025, marking a growth of 95.82% to 121.56% compared to the previous year [10] - Liancheng Precision anticipates a net loss of 12 million to 17 million yuan for 2025, reducing its loss from 37.96 million yuan in the previous year [11] - Beidou Star expects a net loss of 230 million to 290 million yuan for 2025, improving from a loss of 350 million yuan last year [13] Group 5 - Qing Shan Paper's affiliate won a bid for a wastewater treatment project worth 51.9 million yuan [15] - Yiling Pharmaceutical forecasts a net profit of 1.2 billion to 1.3 billion yuan for 2025, recovering from a loss of 725 million yuan in the previous year [16] - Huahai Pharmaceutical received a drug registration certificate for its product used in treating depression and obsessive-compulsive disorder [23] Group 6 - Nanjing Panda expects a net profit of 10 million to 15 million yuan for 2025, turning around from a loss of 189 million yuan last year [40] - Rui Sheng Intelligent anticipates a net profit of 33.92 million to 38.40 million yuan for 2025, representing a growth of 112% to 140% compared to the previous year [41] - Jiechang Drive expects a net profit of 395 million to 437 million yuan for 2025, with a growth of 40% to 55% compared to the previous year [43]

Core Viewpoint - Beidou Star's 2025 annual performance forecast indicates a significant reduction in net loss compared to the previous year, reflecting ongoing strategic adjustments and market opportunities in emerging sectors [1][4] Financial Performance - The company expects a net profit attributable to shareholders of between -290 million yuan and -230 million yuan for 2025, an improvement from -349.74 million yuan in the same period last year [1] - The expected net profit after deducting non-recurring items is projected to be between -350 million yuan and -290 million yuan, also narrowing from -416.62 million yuan year-on-year [1] Business Development - The company is focusing on two main businesses: "smart location digital foundation" and "ceramic components," while building a "cloud-core integration" business model to seize market opportunities [4] - Revenue from chip modules and antenna product lines has significantly increased due to the rapid expansion in emerging fields such as lawn mowers, smart driving, and consumer electronics [4] Strategic Initiatives - The acquisition of Shenzhen Tianli has accelerated the company's antenna business in the automotive market, further expanding its market reach and contributing to profit improvement [4] - The company plans to recognize goodwill impairment of approximately 150 million yuan due to accounting standards and market environment changes [4] - Research and development investment remains high at around 430 million yuan to support the "cloud-core integration" strategy [4] - The company is actively reducing its special equipment business, which has seen a decline in revenue and significant losses [4] Overall Outlook - Beidou Star is characterized by a dual approach of business growth and structural adjustment in 2025, with product lines targeting high-growth sectors gradually contributing to revenue [4] - The company is laying a solid foundation for long-term competitiveness through impairment recognition, focused R&D, and business contraction, with expectations for improved operational quality as strategic adjustments take effect and emerging market demand continues to grow [4]